Evaluation of the safety and efficacy of biosimilar recombinant growth hormone in children with growth hormone deficiency: non-inferiority, randomized, parallel, multicentric and Phase III trial.
Zaeri H, Omidvar S, Servatian N, Arefnia S, Khademolreza N, Amini H, Taghavi B, Hashemipour M, Eshraghi P, Ghasemi M, Ghergherehchi R, Maleki E, Moravej H, Noorian S, Soheilipour F, Dalili S, Kharazmi H, Didban A, Akhlaghi A, Ghaznavi S, Shahbazi M.
Zaeri H, et al. Among authors: ghasemi m.
Expert Opin Drug Saf. 2024 Apr 29. doi: 10.1080/14740338.2024.2348576. Online ahead of print.
Expert Opin Drug Saf. 2024.
PMID: 38682328